Arin Piramzadian, DO
Family Medicine · Jacksonville, NCNPI 1568780591
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,520 of the $2,558 with a category attached, or 98.5%. Pfizer accounts for 98.5% of it on its own, with 2 other manufacturers making up the rest. 2022 is the largest year on record at $2,536, more than ten times the $11 reported in 2020.
Across 4 payments — averaging $639.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
- Fidia Pharma USA Inc.$11
Across 339 payments — averaging $38,532 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$12.7M
- Pfizer$131K
- Eli Lilly$102K
- Sagent Pharmaceuticals$40K
- AstraZeneca$34K
- Regeneron$32K
- plus $28K from 3 others
What the payments were for
- Consulting fees$2,52099%
- Food & beverage$381%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $2,520 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Fidia Pharma USA Inc. | 1 | $11 |
How this compares
$2,558 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $191 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $151 |
| Ciprofloxacin Hcl | 25 | $147 |
| Cephalexin | 21 | $141 |
| Ondansetron OdtOndansetron | 18 | $119 |
| Azithromycin | 23 | $116 |
| Metronidazole | 12 | $104 |
| Prednisone | 32 | $43 |
| Famotidine | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Jacksonville
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.